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Eye tracking (ET) studies are becoming increasingly popular due to rapid 35 
methodological and technological advances as well as the development of cost efficient 36 
and portable eye trackers. Although historically EThas been mostly employed in 37 
psychophysics or developmental cognition studies, there is also promising scope to use 38 
ET for movement disorders and measuring cognitive processes in neurodegeneration. 39 
Particularly, ET can be a powerful tool for cognitive and neuropsychological 40 
assessments of patients with pathologies affecting motor and verbal abilities, as tasks 41 
can be adapted without requiring motor (except eye movements) or verbal responses. In 42 
this review, we will examine the existing evidence of ET methods in neurodegenerative 43 
conditions and its potential clinical impact for cognitive assessment. We highlight that 44 
current evidence for ET is mostly focused on diagnostics of cognitive impairments in 45 
neurodegenerative disorders, where it is debatable whether it has any more sensitivity or 46 
specificity than existing cognitive assessments. By contrast, there is currently a lack of 47 
ET studies in more advanced disease stages, when pati ts’ motor and verbal functions 48 
can be significantly affected, and standard cognitive assessments are challenging or 49 
often not possible. We conclude that ET is a promising method not only for cognitive 50 
diagnostics but more importantly, for potential cognitive disease tracking in progressive 51 
neurodegenerative conditions.  52 
 53 
Key words: Eye tracking; Cognition; Neurodegeneration.  54 
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1. Introduction 55 
Eye tracking (ET) technology is becoming increasingly popular due to the 56 
development of precise, cost efficient, portable and user-friendly eye trackers that can 57 
be used in different settings, facilitating studies in several populations. Indeed, ET has 58 
been shown to be a feasible and valid method used to study cognition in infants (Wass 59 
& Smith, 2014; Boardman & Fletcher-Watson, 2017), healthy adults (Perrin et al., 60 
2017) and several clinical populations  (Bours et al., 2018; Li et al., 2016; García-61 
Blanco et al., 2017). 62 
In addition, ET emerges as a successful communication tool for subjects 63 
suffering from significant verbal and motor impairments. An ET-based communication 64 
system has been tested in Rett syndrome (Vessoyan et l., 2018) and advanced high-65 
tech eye tracking computer systems (ETCS) are already in use as communication tools 66 
in amyotrophic lateral sclerosis (ALS). ETCS are suggested to be highly effective for 67 
locked-in patients, improving their social integration, interaction and quality of life 68 
(Caligari et al., 2013; Spataro et al., 2014; Hwang et al., 2014; Linse et al., 2018).  69 
Eye movement is not a direct measure of brain functio , however it has been 70 
suggested that it can provide additional details into the association between brain and 71 
behaviour, rendering reliable information about higher-order processes that can be 72 
measured by eye position, duration of fixations, pupil size and other measures assumed 73 
to reflect neural mechanisms of learning, memory, attention, as well as other cognitive 74 
functions (Borys & Plechawska-Wójcik, 2017; for reviews see Eckstein et al., 2017; 75 
Luna et al., 2008).  76 
It is not difficult to find studies on eye movements per se in most 77 
neurodegenerative conditions (Meyniel et al., 2005; Garbutt et al., 2008; Chau et al., 78 
2016; Kang et al., 2018), but studies on cognition (Table 1) are much rarer. In part, this 79 
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lack of ET-based cognitive studies is due to the potential presence of oculomotor 80 
dysfunctions in neurodegenerative conditions. These dysfunctions represent real 81 
challenges for ET studies and can act as confounds. However, metrics of oculomotor 82 
function have been shown to correlate with cognitive functions (Shaunak et al., 1995; 83 
Donaghy et al., 2009) and despite the important discus ion on the potential presence of 84 
oculomotor abnormalities, this review will focus onthe proposal that ET can still be a 85 
useful tool so long as patients show preserved gross oculomotor function, but it is 86 
currently an overlooked methodology to study cognitio  in neurodegenerative diseases. 87 
In the following sections, we provide a brief overvi w of ET measures and 88 
applications, and then we summarize some cognitive s udies using ET in mild cognitive 89 
impairment (MCI), Alzheimer’s disease (AD), frontotemporal dementia (FTD), ALS 90 
and Parkinson’s disease (PD). The objective is not to extensively go through the 91 
findings, but to show that ET is an underestimated technology in the study of cognition 92 
(with particular emphasis placed on the study of episodic memory) in neurodegenerative 93 
conditions, when neuropsychological assessment is necessary but limited by motor or 94 
verbal impairments. We have searched Pubmed database for the terms “eye tracking” 95 
and “cognition” in association with “MCI”, “AD”, “FTD”, “ALS” and “PD” and 96 
focused on studies published in the past 20 years, although earlier studies are also 97 
mentioned. 98 
 99 
Table 1 – Overview of ET-based cognitive studies in eurodegenerative diseases in 100 
the past 20 years. 101 
Neurodegenerative 
disorder 
Cognitive processes Recent ET-based cognitive studies 
Mild cognitive 
impairment 
Memory Crutcher et al., 2009; Lagun et al., 2011; 
Zola et al., 2013; Kawagoe et al., 2017; 
Granholm et al., 2015. 




     
Alzheimer´s disease Wayfinding Davis & Ohman, 2016. 
 Memory Dragan et al., 2017; Crutcher et al., 2009; 
Lagun et al., 2011; Crawford et al., 2013; 
Crawford & Higham, 2016; Crawford et 
al., 2017; Brandão et al., 2014; 
Whitehead et al., 2018. 
 Attention Crawford et al., 2015; Chau et al., 2015; 
Chau et al., 2016; Mapstone et al., 2001; 
Viskontas et al., 2011; Rösler et al., 2000. 
 Inhibitory control Hellmut et al., 2012. 
 Perception Shakespeare et al., 2015a; Shakespeare et 
al., 2015b; Boucart et al., 2014; Pavisic et 
al., 2017. 
 Auditory semantic 
processing 
Fletcher et al., 2015a; Fletcher et al., 
2015b; Fletcher et al., 2016. 





Fletcher et al., 2015a; Fletcher et al., 
2015b; Fletcher et al., 2016. 
 Spatial anticipation Primativo et al., 2017. 
 Emotion recognition Hutchings et al., 2018. 
 Inhibitory control Hellmut et al., 2012. 
 Attention Viskontas et al., 2011. 
 Word comprehension Faria et al., 2018; Seckin et al., 2016. 
      
Amyotrophic lateral 
sclerosis 
Executive function Hicks et al., 2013; Proudfoot et al., 2016; 
Keller et al., 2017; Keller et al., 2016; 
Keller et al., 2015; Poletti et al., 2017a; 
Poletti et al., 2017b; Poletti et al., 2018.  
 Verbal fluency Cipresso et al., 2013. 
      
Parkinson´s disease Memory Crutcher et al., 2009;  Fukushima et al., 
2015.  
 Attention Wong et al., 2018; Norton et al., 2016 
 Inhibitory control Wang et al., 2016; Ranchet et al., 2017;  
Turner et al., 2017. 
 Language Lee & Hsieh, 2017; Hochstad et al.,  
2009. 
 102 
2. The oculomotor functions 103 
The eyes make different types of movements when we look at a target: saccades 104 
are meant to be rapid eye movements that entail ampitude and direction, aiming to 105 
reposition the eyes from one target to another afte fixation, when the eyes remain still 106 
for very short period (although not completely still due to nystagmus, drifts and 107 
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microsaccades - small movements often considered noise; Duchowski, 2017). Fixations 108 
are considered to be voluntary manifestation of attention and it is suggested that new 109 
information is only acquired in this phase, while saccades indicate a change in the focus 110 
and as such no information is obtained due to the rapid eye movement and consequent 111 
suppression of vision (Rayner, 2009; Duchowski, 2017). Pursuit occurs when the eyes 112 
follow a moving object or target. Vergence are movements to adjust or accommodate 113 
the eyes (specifically the fovea) to objects at different distances from the observer. 114 
Finally, vestibular movements serve as a compensation for head and body motion, to 115 
accommodate and keep the direction of the gaze (Rayner, 1998). To these movements 116 
we can add pupil dilation, a non-positional measure associated with adaptation. 117 
Saccadic movements and fixations are the most relevant measures used in ET studies, 118 
although pursuit and pupil dilation studies are often found (Gooding et al. 2000; Garbutt 119 
et al., 2008; Gerven et al., 2004). 120 
Different muscles, brain structures and pathways command these eye 121 
movements and detailed discussion of this is beyond the scope of this review (for 122 
information on the oculomotor neuroanatomy, we refer the readers to Duchowski, 123 
2017). For obvious reasons, the integrity of the ocul motor system will be critical for 124 
eye movement control. However, despite the possibility that oculomotor dysfunction 125 
can be problematic in neurodegenerative disorders, ET studies are not impracticable as 126 
will be demonstrated here. 127 
3. Eye tracking methodology 128 
Today´s most commonly used ET method is based on infra-red light to track 129 
corneal reflection and the centre of the pupil (Cornsweet & Crane, 1973; Guestrin and 130 
Eizenman, 2006). This method requires the head to be stable so eye’s position relative 131 
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to the head and point of regard (POR) coincide, however modern eye trackers present a 132 
very fast recovery rate in the case of head movement. 133 
Importantly, this system requires calibration, a procedure necessary to allow the 134 
eye tracker to calculate the POR. Experiments should be short in order to allow frequent 135 
calibration. Calibration issues are common for several reasons and may compromise the 136 
accuracy of the data recorded, often causing the exclusion of data or participants. Visual 137 
acuity is required, and the use of varifocal or contact lenses can possibly cause 138 
reflections and therefore interfere with data collection (although some modern eye 139 
trackers can capture signal in the presence of corre tive lenses). Other issues include 140 
eyelid dysfunction and obstruction, which are frequnt problems found in aging (Salvi 141 
et al., 2006; Hamedani, 2017). Long eyelashes may also interfere with the ability of the 142 
eye tracker to locate the corneal reflection (Duchowski, 2017).  143 
An additional source of methodological issues is related to the analysis of the 144 
data. Care must be taken to eliminate noise (usually eye instability and blinks), to 145 
choose the approach to consider detection of fixations or saccades (a threshold needs to 146 
be established), and null POR may be recorded for one eye but not the other (a common 147 
problem due to poor calibration). Even the amount of data recorded can be a challenge, 148 
especially if the experiment has a large number of participants and the sampling rate is 149 
high (which can be a problem even if the experiment is short). 150 
 151 
4. Eye tracking and cognition 152 
Different approaches can be adopted to study cogniti n with ET. Traditional 153 
tasks measuring oculomotor movements that act as proxy markers of cognitive 154 
performance (e.g. the antisaccade task explained on section 4.1), ET-based cognitive 155 
tasks (e.g. the TMT or d2 tests mentioned on section 6.4) and other cognitive tasks 156 
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specifically designed to measure particular cognitive functions  (e.g. relational memory 157 
and binding tasks mentioned on section 4.2) can provide additional insights in the study 158 
of cognition. In addition, ET has the potential to be used as a communication tool to 159 
collect answers (as shown in Figure 1). The idea behind it is that for patients presenting 160 
with prominent language and motor dysfunctions which prevent them from verbally 161 
answering or clicking at a computer mouse or any other button, instead the answer 162 
could be written on the computer screen and the pati nt would simply fixate the gaze on 163 
the chosen answer. Talk and colleagues (2017) have studied source memory by showing 164 
objects in different quadrants on the screen and participants were later requested to 165 
indicate if the object was previously seen and in what position, however the answers 166 
were given verbally. Such a task could be easily adapted to ET to facilitate testing of 167 
patients with language and motor difficulties. Development of tasks that use ET as a 168 
simple communication tool would not depend on fine oculomotor movements and 169 
would not require the precision of typical ET metrics. Patients’ responses would be 170 
indicated by fixations on the written answer on the screen, but the practical simplicity of 171 
implementing this idea remains unexplored. 172 
 173 




ET used as a communication tool to study cognition: n this hypothetical memory test, a figure is shown 176 
and later the patient is requested to answer if the figure was previously shown or not. The answer is 177 
obtained by the patient fixating their gaze on the answer (i.e. “NEW” or “OLD” answer).  178 
 179 
4.1 Executive function 180 
The antisaccade task (Hallet, 1977) is a classic example of a task to assess 181 
frontal lobe dysfunctions. In this task, the subject is requested to supress saccades 182 
towards a specific target and instead to generate saccades in the opposite direction.  This 183 
task measures inhibition and can therefore provide nformation on executive 184 
functioning. In turn, in the prosaccade task, the subject is requested to generate a 185 
saccades towards the target (Hellmuth et al., 2012). 186 
Interestingly, recent studies have used ET to adapt traditional 187 
neuropsychological executive functioning tests liketh  Iowa Gambling Task (IGT), the 188 
Modified Card Sorting Test (MCST), d2 test and the Trail Making Test (TMT; Poletti et 189 
al., 2017; Hicks et al., 2013). These studies have found substantial correlation between 190 
the ET-based assessments and standard paper and pencil administration of these tests, 191 
thus confirming the ET validity and reliability in establishing performance on executive 192 
functions. Moreover, these studies represent an important step towards 193 
neuropsychological assessment of populations presenting with verbal and motor 194 
dysfunction that hinder the use of traditional paper and pencil tests. 195 
 196 
4.2 Memory 197 
Converging evidence suggests that eye movement behaviour reveals different 198 
mnemonic processes,  including before or even in the absence of conscious recollection 199 
(for a review see Hannula et al, 2010). Several studies in healthy and clinical 200 
populations, from infants to the aging population have attempted to study memory 201 
processes using ET (Kafkas & Montaldi, 2012; Nemeth et al., 2016; Oakes et al., 2013; 202 
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Richmond & Nelson, 2009). Particularly interesting s the use of ET to study memory in 203 
preverbal infants as behavioural reports cannot be obtained in this population. Likewise, 204 
in some neurodegenerative conditions as ALS or late stages of AD, when verbal reports 205 
may not prevail or be reliable, ET emerges as a powerful method to study memory 206 
without elaborated task instructions, complex decision-making requirements or verbal 207 
skills required from patients. 208 
The   visual paired comparison task (VPC) appears as a compelling option to test 209 
episodic memory as it is suggested to be specific for declarative memory and sensitive 210 
to hippocampal damage (Crutcher et al., 2009; Zola et al., 2013). The VPC task consists 211 
of the presentation of an object (or image) and after a delay, the object is presented 212 
again side-by-side with a new one and the amount of time the participant spends 213 
exploring each object is measured.  Depending on the test delay, the participant is 214 
expected to spend more time looking at the novel object, due to the novelty preference. 215 
This task has been successfully tested in primates (Zola et al., 2000), rodents (Clark et 216 
al., 2000), infants (Oakes & Kovack-Lesh, 2013), healthy older adults (Manns et al., 217 
2000) and clinical populations (Chau et al., 2015). Primates with lesions in the 218 
hippocampal area have shown important recognition impa rment detected by the VPC 219 
task, and the impairment was in fact more robust than during a nonmatching to sample 220 
task (Zola et al., 2000). Similarly, rodents with eith r thermocoagulation or excitotoxic 221 
lesions in hippocampus or surrounding areas showed no preference for the novel object 222 
(Clark et al., 2000). The novelty preference (Snyder et al., 2008) is consistently 223 
observed in infants and the VPC task is widely used in this population (Fagan, 1990). 224 
Recently, the Fagan Test of Infant Intelligence (a VPC task) was adapted to ET and 225 
tested in HIV exposed children (Boivin et al., 2017).  In adults, both in healthy and 226 
clinical populations the VPC task was found to be a good measure of recognition 227 
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memory with the potential to predict normal adults who will convert to MCI and 228 
patients with MCI who will convert to AD (Crutcher t al., 2009; Lagun et al., 2011; 229 
Zola et al., 2013). Although this task only investiga es the recognition aspect of 230 
memory, it opens a new perspective to study memory in clinical populations. 231 
Some ET-based studies have attempted to investigate memory differentiating 232 
recollection and familiarity processes which are know  to be two different aspects of 233 
episodic memory recognition (for a review see Yonelinas, 2002). Studying eye 234 
movement behaviour in young adults during encoding, and using a remember/know 235 
adapted paradigm after having trained the participants to identify the strength of the 236 
memory, Kafkas and Montaldi (2011) have shown different patterns of fixations that 237 
could differentiate recognition based on recollection from those based on familiarity. 238 
The method used relied on the subjective experience of the participant regarding 239 
feelings of “I remember” or “I know”, but distinct patterns of fixations were shown for 240 
each process (recollection or familiarity) and the number of fixations at encoding were 241 
shown to be associated later with the strength of the memory. Similar findings were 242 
reported in an elegant study using ET and functional m gnetic resonance imaging 243 
(fMRI; Kafkas & Montaldi, 2012). In this study, the authors not only reported distinct 244 
patterns of fixations but also showed brain activation in areas that support recollection 245 
and familiarity (notably hippocampus and perirhinal cortex, respectively, although a 246 
discussion on the roles of these regions is beyond the scope of this work. For a review 247 
see  Diana et al., 2007).  248 
Different eye movement patterns have also been related to hippocampal activity 249 
associated with memory, even without overt accurate decisions (Hannula & Ranganath, 250 
2010; Liu et al., 2018), and the area is also report d as necessary to generate relational 251 
binding eye-movement effects (for review see Pathman & Ghetti, 2016) ). In fact, 252 
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relational binding, a critical component of episodic memory has been investigated in a 253 
number of studies using a variety of materials such as faces and scenes, and such eye 254 
movements have been demonstrated to be influenced by memory (Ryan et al., 2000; 255 
Ryan et al., 2007a; Ryan et al., 2007b). Inhibition f irrelevant information and 256 
impaired binding are suggested to be problematic in normal aging and contribute to 257 
memory decline (Ryan et al., 2007b), but most neurodegenerative diseases have not 258 
been studied using these methods and the reliability and feasibility of the tasks used in 259 
those studies still need to be elucidated in neurodegeneration. Likewise, studies of  the 260 
recognition of facial emotion expression in patients with amygdala damage (Adolphs et 261 
al., 2005) and recognition of familiar faces in patien s with prosopagnosia (Stephan & 262 
Caine, 2009) have been linked to atypical face scan patterns, but this area also remains 263 
unexplored in neurodegeneration. 264 
 Moreover, pupil dilation, an involuntary reaction, ot only related to the 265 
dark/light response, but also associated with cognitive effort or arousal, has been 266 
demonstrated in memory studies and is suggested to be a reliable memory measure 267 
(Irwin, Lippa, & Swearer, 2007; Võ et al., 2008; Goldinger & Papesh, 2014). Increases 268 
in pupil size are detected when the participant recognizes an object previously shown 269 
and these increases are suggested to be correlated with the strength of the memory 270 
(Kafkas et al., 2011). However, although experiments measuring pupil size require 271 
controlled conditions of light and the exclusion of certain medications (we refer the 272 
most curious readers to the works of Aston-jones & Cohen, 2005 and Usher et al., 273 
1999), it appears to be  an effective option to study memory (Papesh et al., 2012; 274 
Kucewicz et al., 2018).  275 
 276 
4.3 Language and social cognition 277 
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Recently, Poletti and colleagues (2017) have developed an ET-based version of 278 
the Token Test and the Reading the Mind in the Eyes Test. In their study, they observed 279 
significant correlations between the ET-based tests and the paper and pencil screening 280 
tests used: The Frontal Assessment Battery (FAB) and the Montreal Cognitive 281 
Assessment (MoCA). In addition, they investigated the usability of the method and 282 
found that the level of motivation of the subject could influence their performance while 283 
using a new technology. Although only tested in healt y participants and with 284 
questionable construct validity as both FAB and MoCA are bedside screening tests, the 285 
study represents an important step towards the developm nt of a cognitive assessment 286 
battery that is not dependent on speech and motor function, which could be potentially 287 
used in several pathological conditions suffering from verbal or motor difficulties.   288 
 289 
4.4 Spatial navigation 290 
How people interact with the surrounding environment, a d how they explore, 291 
interpret and make decisions regarding spatial navigation has long been studied using 292 
ET. Analyses of pupil size have been used to study navigation strategies as well as 293 
measures of fixations and gaze position, providing information about the allocation of 294 
perceptual attention and integration of information (Condappa & Wiener, 2014; Mueller 295 
et al., 2008; for a review see Kiefer et al., 2017). Interestingly, in the past, research was 296 
restricted to laboratories, but recent technologies provide now the possibility to study 297 
spatial navigation in real situations and in real time (Kiefer et al., 2014; Wenczel et 298 
al.,2017). 299 
5. Eye movement control in neurodegenerative disorders 300 
Abnormal oculomotor findings are frequent in neurodegenerative conditions as 301 
eye movement control depends on extensive brain structures and networks that are 302 
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frequently damaged during the course of the diseases (for reviews see Antoniades & 303 
Kennard, 2014; Gorges et al., 2014). Oculomotor dysfunction may be present from 304 
early disease stages as it is known to happen in PD (for a review see Gorges et al., 305 
2014), or may appear in late disease stages as it is traditionally regarded in ALS, 306 
although some studies show ALS can have impairments of eye movements from 307 
relatively early stages (Kang et al., 2018; for a review see Sharma et al., 2011). 308 
Importantly, eye movement disorders are suggested to be effective to track disease 309 
severity and progression in AD (Anderson & MacAskill, 2013; for a review see Pereira 310 
et al., 2014) and in movement disorders (for a review see Gorges et al., 2014).  311 
 312 
6. ET-based cognitive studies in neurodegeneration 313 
6.1 Mild cognitive impairment  314 
MCI is characterised by a cognitive decline that is not expected for the patient´s 315 
age, and episodic memory is particularly affected, while everyday functional abilities 316 
usually remain intact (for review see Portet et al., 2006). Although the cognitive decline 317 
is not great enough to meet diagnostic criteria for frank dementia, MCI patients are at an 318 
increased risk of developing dementia in the near future (Vega & Newhouse, 2014). 319 
Crutcher and colleagues (2009) studied memory in MCI patients using a VPC task. 320 
Patients performed worse on the VPC task compared with healthy controls and PD 321 
patients when the delay was increased. Interestingly, one MCI patient without 322 
significant brain or hippocampal changes in magnetic resonance imaging (MRI), 323 
showed low performance on the VPC task (characterising memory impairment), and the 324 
authors suggested that impairments in this task may be detectable before macroscopic 325 
structural damage to the hippocampus are apparent. However, this patient also showed 326 
signs of white matter changes that could explain the low performance on the test. The 327 
task has also been suggested by the authors to have som  predictive power to show 328 
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which MCI patients will convert to AD (Zola et al., 2013). Further, impairments of 329 
inhibitory control were found in MCI patients performing an anti-sasccade task 330 
combined with fMRI (Alichniewicz et al., 2013). 331 
 332 
6.2 Alzheimer´s disease  333 
The most prevalent cause of dementia, AD is known to affect different cognitive 334 
processes, with significant episodic memory dysfunctio  from the early stages of the 335 
disease, but also with impairments in semantic knowledge, language and visuospatial 336 
abilities as well as executive dysfunctions (Bondi et al., 2017). Lagun and colleagues 337 
(2011) have used a VPC task combined with classificat on algorithms and machine 338 
learning methods to successfully distinguish between h althy participants, MCI and AD 339 
patients. Although the VPC task is suggested to be sensitive to hippocampal impairment 340 
(Manns et al., 2000), it is still underused in AD.  Pupil changes have been measured in 341 
AD in relation to light stimulus (Fotiou et al., 2009; Fotiou et al., 2007; Fotiou et al., 342 
2015) or to evaluate cholinergic deficits (Frost et al., 2017; Fotiou et al., 2009), but few 343 
studies have examined it in relation to memory (Dragan et al., 2017). Though evaluating 344 
episodic memory by the pupil size effect (Võ et al,  2008) is a method shown to be 345 
effective (Kucewicz et al., 2018; Naber & Marburg, 2018; for review see Goldinger & 346 
Papesh, 2014), it is also underexplored in AD. This method can be used when task 347 
comprehension or verbal response is impaired, which could be useful to study AD in 348 
later stages.  349 
Spatial disorientation is another important feature in AD (for a review see 350 
Coughlan et al., 2018) and ET-based spatial navigation research is well stablished (for a 351 
review see Kiefer et al., 2017). Wayfinding in AD has been investigated by Davis & 352 
Ohman (2016), but although modern eye trackers allow participants to walk or perform 353 
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other tasks during the experiment, making ET a powerful tool to study spatial 354 
navigation, the area remains virtually unexplored in AD.  355 
Attentional processes and working memory have been studied mostly using the 356 
prosaccade and antisaccade task (Crawford et al., 2015; Crawford et al., 2013; Crawford 357 
et al., 2017; Crawford & Higham, 2016), but also a variety of other tasks have been 358 
used (Brandão et al., 2014; Chau et al., 2015; Chau et l., 2016; Mapstone et al., 2001; 359 
Viskontas et al., 2011; Rösler et al., 2000), including reading (Fernández et al., 2016) 360 
and finding objects in a natural scene (Dragan et al., 2017). Given the several different 361 
cognitive domains affected in AD, ET is potentially a useful tool to further investigate 362 
cognition rather than relying only on classic paper and pencil tests. 363 
 364 
6.3 Frontotemporal dementia 365 
FTD is the general name given to a type of dementia known to affect 366 
predominantly the frontal and temporal lobes. The most common form of FTD is known 367 
as behavioural FTD (bvFTD), but FTD also includes three language variants - the 368 
primary progressive aphasias (PPA): semantic variant (svPPA), agramatic/nonfluent 369 
variant (anvPPA) and logopenic variant (lvPPA; Bonner & Grossman, 2011; for a 370 
review see Hodges & Piguet, 2018). Interestingly, based on the Brixton spatial 371 
anticipation test, Primativo and colleagues (2017) developed an ET-based spatial 372 
anticipation test and assessed bvFTD and svPPA patients. They found higher rates of 373 
impairment in bvFTD compared with healthy controls and svPPA patients, confirming 374 
previous results of spatial anticipation impairment in bvFTD, including those which 375 
used an antisaccade task (Burrell et al., 2012; Hornberger et al., 2011). Pupil responses 376 
were evaluated in a series of studies investigating auditory stimulus, comparing bvFTD, 377 
svPPA, anvPPA, AD and healthy controls (Fletcher et al., 2015a; Fletcher et al., 2015b; 378 
Fletcher et al., 2016). These studies demonstrated the utility of ET in the dementias to 379 
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study autonomic and behavioural responses to stimulus when language is impaired. 380 
Regarding language processing in the FTD language vriants, two elegant studies show 381 
that ET is an interesting option showing superiority in demonstrating impairments over 382 
traditional tests, including distinguishing between the language variants (Seckin et al., 383 
2016; Faria et al., 2018). 384 
 385 
6.4 Amyotrophic lateral sclerosis 386 
ALS is a fatal disease of motor neurons, but a proportion of patients also present 387 
a variety of behavioural and cognitive changes (Strong et al., 2017), even when not 388 
meeting criteria for diagnosis of FTD (for reviews see Kiernan et al., 2011; Goldstein & 389 
Abrahams, 2013). However, studying cognition in ALS can be a challenge as the 390 
disease progresses and the patient’s language and motor functions become severely 391 
impaired. 392 
Particularly in ALS, ET methods have recently been applied with a different 393 
perspective, making it potentially possible to communicate with patients for 394 
neuropsychological assessment. In addition to the TMT study adapted by Hicks and 395 
colleagues (2013), another TMT study assessed executiv  f nctions and visual search in 396 
ALS patients (Proudfoot et al., 2016), who showed an impairment on the tasks, and 397 
interestingly the authors used the ET to show that ere was no progression detected 398 
longitudinally. Moreover, this study shows that thestability of oculomotor function over 399 
time in ALS may accredit the usability of ET as a potential tool to study cognition 400 
longitudinally in this population as they get severely impaired physically with disease 401 
progression.  402 
Antisaccade tasks combined with fMRI have also been performed and the results 403 
suggested deficits of executive functioning (Witiuk et al, 2014). The Raven’s Coloured 404 
Progressive Matrices and the d2-test were also recently adapted to ET (Keller et al., 405 
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2015; Keller et al., 2016) and the ET-based versions f the tests showed reliability in 406 
distinguishing the patients who were more or less impaired. The widely used cognitive 407 
screening battery for ALS, the Edinburgh Cognitive and Behavioural ALS Screen 408 
(ECAS; Abrahams et al., 2014) also gained an ET version reliably able to distinguish 409 
impaired from non-impaired patients with high specificity (Keller et al., 2017).  The 410 
Phonemic and Semantic Verbal Fluency Test was tested in another feasibility study and 411 
the authors provided evidence of the effectiveness and usability of the method (Cipresso 412 
et al., 2013). Finally, an ET-based version of the Arrows and Colours Cognitive Test 413 
was recently developed and reported to be a potential tool to test cognitive flexibility, 414 
overcoming verbal and motor impairments present in ALS patients  (Poletti et al., 415 
2018). It is evident that recently great effort has been made to adapt traditional tests to 416 
ET, aiming to overcome verbal and motor impairments i  ALS, however, despite the 417 
successful studies, several cognitive domains remain unexplored. 418 
 419 
6.5 Parkinson’s disease 420 
Parkinson’s disease (PD) is a progressive neurodegenerative condition affecting 421 
the basal ganglia, therefore presenting predominantly motor symptoms; however 422 
considerable cognitive impairments can also be present from early disease stages (for a 423 
review see Dubois & Pillon, 1997). As in other neurodegenerative diseases, ET-based 424 
cognitive studies are overlooked in PD, with few cognitive domains being explored 425 
using these methods. In the memory domain, smooth pursuit has been explored as well 426 
as saccades and fixations, showing impairments in different levels (Crutcher et al., 427 
2009; Fukushima et al., 2015; Fukushima et al., 2017; Wong et al., 2018). Executive 428 
functions such as attention (Norton et al., 2016) and inhibitory control (Wang et al., 429 
2016; Ranchet et al., 2017; Turner et al., 2017) were studied using measures including 430 
pupil response, fixations and saccades and using different tasks such as the prosaccade 431 
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and antisaccade tasks, as well as object tracking. These studies report impairments in 432 
PD associated with cognitive workload (Ranchet et al., 2017) and suggest that they are 433 
independent from oculomotor processing (Norton et al., 2016). Language planning and 434 
comprehension (Lee, 2017; Hochstadt, 2009) have also been assessed using ET in PD. 435 
Although some ET-based studies in PD can be found, Wong and colleagues (2018) 436 
nicely state that cognitive assessments in PD patients are often limited by their motor 437 
conditions, and as such a methodology like ET to study cognition in these cases is 438 
proven to be highly convenient. ET clearly shows the potential to study cognition 439 
longitudinally and further studies are warranted to elucidate disease progression in 440 
terms of cognitive aspects. 441 
7. Methodological challenges for ET use in neurodegeneration 442 
Notably, ET measures can offer additional information to complement and refine 443 
the study of cognition in neurodegeneration, though several challenges need to be 444 
addressed. Attentional dysfunction present in many neurodegenerative conditions may 445 
interfere with oculomotor control (Scinto, et al., 1994). Further, patients may require to 446 
be prompted as reported in the study of Proudfoot and colleagues (2016). Some drugs 447 
used to treat neurodegeneration patients  are known t  affect the oculomotor function 448 
and can potentially interfere with the results (e.g. dopaminergic medication; Pinkhardt 449 
et al., 2012). Given considerable changes in eye move ent latencies and other 450 
oculomotor dysfunctions, adaptation for stimulus presentation as well as for data 451 
analyses may also be considered, especially for patients in advanced disease stages. ET 452 
requires relatively stable head/eye position in order to sample data accurately, which 453 
might not be always possible even when using a chinrest, depending on the patients’ 454 
physical and/or psychological conditions. Although some modern eye trackers allow 455 
head movement and present a fast recovery rate, some data loss should be expected. 456 
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Lastly, the use of eyeglasses or contact lens is comm n in the aging population, so 457 
despite the relative simplicity of modern eye trackers, system calibration issues should 458 
be expected. 459 
8. Concluding remarks 460 
Despite confounding issues and difficulties from data acquisition to data 461 
analysis, the above reported studies show that ET opens a window to the study of 462 
cognition in neurodegeneration and presents areas th t remain unexplored. In this 463 
review, we demonstrate the current evidence of ET´s advantages to assess cognitive 464 
functions in neurodegenerative conditions despite there being currently relatively few 465 
ET-based studies on cognition, either using oculomot r-based metrics or cognitive 466 
tasks. Notably, different eye measures can be obtained simultaneously in the same 467 
session and will offer different information for specific processes, providing 468 
complementary information in low cost experiments, compared with other techniques 469 
(e.g. fMRI).  470 
Eye movements provide valid measures of cognition, but few studies to date 471 
have explored ET as a communication tool to assess cognitive processes in 472 
neurodegeneration. This potential use of ET does not require precise oculomotor 473 
function and could be explored to establish the feasibility and reliability of ET to study 474 
cognition in neurodegenerative conditions.  475 
Despite efforts that have been made to adapt some executive functioning tests to 476 
ET, a variety of other cognitive domains and traditional neuropsychological batteries 477 
still need to be adapted and standardized, and their us  in contexts where traditional 478 
tests are prevented due to verbal and motor impairments is yet to attract attention from 479 
researchers and clinicians. A complete battery of ET-based neuropsychological 480 
assessments would be highly convenient for patients, re earchers and healthcare 481 
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professionals to reduce linguistic and motor demands on the patients or to overcome 482 
severe language and motor dysfunctions.  483 
Of note is that virtually all of the presented studies were conducted in early 484 
disease stage patients, while none have used ET in more advanced disease stages. 485 
Cognitive testing in advanced neurodegenerative patients is problematic, but ET can 486 
potentially overcome verbal and motor limitations, emerging as a potential tool to 487 
investigate cognition in advanced conditions, facilitat ng longitudinal disease tracking 488 
studies. There would be clearly a benefit to assess more advanced patients, not only in 489 
terms of research and better understanding of the patho hysiology of the conditions 490 
here discussed, but also for decisions on treatment and intervention plans. Although 491 
there are currently no disease-modifying therapies for these neurodegenerative 492 
conditions, understanding disease processes in later stages and how they might impact 493 
the patient´s well-being is critical to assist patien s in their needs, offer appropriate 494 
support whenever possible and to develop novel supportive end of life care.   Despite 495 
some studies showing the potential of ET to investigate cognition in neurodegeneration, 496 
this area needs to be further explored to establish how feasible and reliable is the use of 497 
ET in advanced neurodegeneration stages, despite oculomotor dysfunction which may 498 
be present in some conditions in late disease stages.  499 
ET emerges as a useful and exciting tool to screen for and measure cognitive 500 
abnormalities, and to track disease severity and progression. The standardization of ET-501 
based tests can potentially reduce variability and inconsistency of results, benefiting 502 
researchers, healthcare professionals and patients, and specially offering the possibility 503 
of testing cognition longitudinally or in later disease stages, when patients can be 504 
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• Neuropsychological assessments via eye tracking can potentially overcome 
verbal and motor dysfunctions present in neurodegenerative conditions. 
• Eye tracking can be used for cognitive diagnostics, but also for potentially 
tracking cognitive dysfunction in progressive neurodegenerative conditions. 
• Eye tracking may serve as a tool to investigate cognition in later stages of 
neurodegenerative diseases. 
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